Avalo Therapeutics, Inc. earnings per share and revenue

AVTX earnings per share for the last quarter are -2.83 USD whereas the estimation was -1.19 USD which accounts for -137.82% surprise. Company revenue for the same period amounts to 249.00 k USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -1.42 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of AVTX earnings per share and revenue dynamics.